The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Cystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Abstract
The natural history of cystic fibrosis lung disease is one of chronic progression with intermittent episodes of acute worsening of symptoms frequently called acute pulmonary exacerbations These exacerbations typically warrant medical intervention. It is important that appropriate therapies are recommended on the basis of available evidence of efficacy and safety. The Cystic Fibrosis Foundation therefore established a committee to define the key questions related to pulmonary exacerbations, review the clinical evidence using an evidence-based methodology, and provide recommendations to clinicians. It is hoped that these guidelines will be helpful to clinicians in the treatment of individuals with cystic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Rabe, K. F., Hurd, S., Anzueto, A., Barnes, P. J., Buist, S. A., Calverley, P., Fukuchi, Y., Jenkins, C., Rodriguez-Roisin, R., van Weel, C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200703-456so · Cited by 4,925
Synergy, antagonism, and what the chequerboard puts between them
Odds, F. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg301 · Cited by 2,481
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
Fuchs, H. J., Borowitz, D. S., Christiansen, D. H., Morris, E. M., Nash, M. L., Ramsey, B. W., Rosenstein, B. J., Smith, A. L., & Wohl, M. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311003 · Cited by 1,539
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
Ramsey, B. W., Pepe, M. S., Quan, J. M., Otto, K. L., Montgomery, A. B., Williams-Warren, J., Vasiljev-K, M., Borowitz, D., Bowman, C. M., Marshall, B. C., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400104 · Cited by 1,300
Self-citationMoore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Cystic Fibrosis Pulmonary Guidelines: Chronic Medications for Maintenance of Lung Health
Flume, P. A., O'Sullivan, B. P., Robinson, K. A., Goss, C. H., Mogayzel, P. J., Willey-Courand, D. B., Bujan, J., Finder, J., Lester, M., Quittell, L., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-664oc · Cited by 1,024
Self-citationSaiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Self-citationCorrelation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus
Döring, G., Conway, S. P., Heijerman, H. G. M., Hodson, M. E., Høiby, N., Smyth, A., Touw, D. J., & the Consensus Committee, F. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d30.x · Cited by 620
Consensus Report on Nutrition for Pediatric Patients With Cystic Fibrosis
Borowitz, D., Baker, R. D., & Stallings, V. (2002) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.2002.tb07816.x · Cited by 581
Microbiology of airway disease in patients with cystic fibrosis
Gilligan, P. H. (1991) · Clinical Microbiology Reviews · doi:10.1128/cmr.4.1.35 · Cited by 529
Single or multiple daily doses of aminoglycosides: a meta-analysis
Barza, M., Ioannidis, J. P., Cappelleri, J. C., & Lau, J. (1996) · BMJ · doi:10.1136/bmj.312.7027.338 · Cited by 450
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Self-citationAssociation of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90358-9 · Cited by 418
Moore, R. D., Smith, C. R., & Lietman, P. S. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/149.3.443 · Cited by 390
Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis
Britto, M. T., Kotagal, U. R., Hornung, R. W., Atherton, H. D., Tsevat, J., & Wilmott, R. W. (2002) · Chest · doi:10.1378/chest.121.1.64 · Cited by 347
Cystic Fibrosis Pulmonary Guidelines: Airway Clearance Therapies
Flume, P. A., Robinson, K. A., O'Sullivan, B. P., Finder, J. D., Vender, R. L., Willey-Courand, D.-B., White, T. B., & Marshall, B. C. (2009) · Respiratory Care · doi:10.4187/respcare.09540522 · Cited by 343
Self-citationSmith, A. L., Fiel, S. B., Mayer-Hamblett, N., Ramsey, B., & Burns, J. L. (2003) · Chest · doi:10.1378/chest.123.5.1495 · Cited by 307
Diagnosis, screening and management of cystic fibrosis related diabetes mellitus
Moran, A., Hardin, D., Rodman, D., Allen, H. F., Beall, R. J., Borowitz, D., Brunzell, C., Campbell III, P. W., Chesrown, S. E., Duchow, C., et al. (1999) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(99)00058-3 · Cited by 293
Regelmann, W. E., Elliott, G. R., Warwick, W. J., & Clawson, C. C. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.4_pt_1.914 · Cited by 262
Aaron, S. D., Vandemheen, K. L., Ferris, W., Fergusson, D., Tullis, E., Haase, D., Berthiaume, Y., Brown, N., Wilcox, P., Yozghatlian, V., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67060-2 · Cited by 240
Smyth, A., Tan, K. H.-V., Hyman-Taylor, P., Mulheran, M., Lewis, S., Stableforth, D., & Knox, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17906-9 · Cited by 228
Sawaya, G. F., Guirguis-Blake, J., LeFevre, M., Harris, R., Petitti, D., & for the U.S. Preventive Services Task Force (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-12-200712180-00007 · Cited by 188
Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
Al-Aloul, M., Miller, H., Alapati, S., Stockton, P. A., Ledson, M. J., & Walshaw, M. J. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20138 · Cited by 178
Saiman, L., Mehar, F., Niu, W. W., Neu, H. C., Shaw, K. J., Miller, G., & Prince, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.532 · Cited by 164
Mucociliary clearance in cystic fibrosis
Robinson, M., & Bye, P. T. B. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10079 · Cited by 158
Smith, A. L., Doershuk, C. F., Goldmann, D. A., Gore, E., Hilman, B. C., Marks, M. I., Moss, R. B., Ramsey, B. W., Redding, G. J., Rubio, T. T., et al. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70197-6 · Cited by 140
Inhalation of antibiotics in cystic fibrosis
Touw, D. J., Brimicombe, R., Hodson, M. E., Heijerman, H. G. M., & Bakker, W. M. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08091594 · Cited by 139
Wolter, J. M., Bowler, S., Nolan, P., & McCormack, J. G. (1997) · European Respiratory Journal · doi:10.1183/09031936.97.10040896 · Cited by 138
Conway, S. P., Pond, M. N., Watson, A., Etherington, C., Robey, H. L., & Goldman, M. H. (1997) · Thorax · doi:10.1136/thx.52.11.987 · Cited by 136
Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis
Smyth, A. R., Bhatt, J., & Nevitt, S. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002009.pub6 · Cited by 133
McLaughlin, F. J., Matthews, W. J., Strieder, D. J., Sullivan, B., Taneja, A., Murphy, P. G., & Goldmann, D. A. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.3.559 · Cited by 124
Hodson, M., Butland, R. J. A., Roberts, C. M., Smith, M. J., & Batten, J. C. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90062-6 · Cited by 120
Pharmacokinetic and Pharmacodynamic Issues in the Treatment of Bacterial Infectious Diseases
McKinnon, P. S., & Davis, S. L. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1107-7 · Cited by 120
Remschmidt, H., & Schmidt, M. H. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_47 · Cited by 109
Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease
Donati, M. A., Guenette, G., & Auerbach, H. S. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80337-2 · Cited by 109
Beaudry, P. H., Marks, M. I., McDougall, D. M., et al. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80155-7 · Cited by 105
Patterns of medical practice in cystic fibrosis: Part II. Use of therapies
Konstan, M. W., Butler, S. M., Schidlow, D. V., Morgan, W. J., Julius, J. R., & Charles A. Johnson, M. (1999) · Pediatric Pulmonology · Cited by 92
Re-evaluating current antibiotic therapy
Craig, W. A. (2001) · Respiratory Medicine · doi:10.1016/s0954-6111(01)90023-x · Cited by 90
Hyatt, A. C., Chipps, B. E., Kumor, K. M., Mellits, E. D., Lietman, P. S., & Rosenstein, B. J. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80486-6 · Cited by 87
Saiman, L. M. (2007) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2007.04.006 · Cited by 85
Pond, M. N., Newport, M. J., Joanes, D. N., & Conway, S. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07091640 · Cited by 74
Gold, R., OVERMEYER, A., KNIE, B., Fleming, P. C., & Levison, H. (1985) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198503000-00012 · Cited by 74
Duration of intravenous antibiotic therapy in people with cystic fibrosis
Plummer, A., Wildman, M. J., & Gleeson, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006682.pub5 · Cited by 71
Home intravenous antibiotic treatment in cystic fibrosis.
Gilbert, J., Robinson, T., & Littlewood, J. M. (1988) · Archives of Disease in Childhood · doi:10.1136/adc.63.5.512 · Cited by 70
Falagas, M. E., Avgeri, S. G., Matthaiou, D. K., Dimopoulos, G., & Siempos, I. Ι. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn201 · Cited by 69
Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis
Bosworth, D. G., & Nielson, D. W. (1997) · Pediatric Pulmonology · Cited by 69
RICHARD, D. A., Nousia‐Arvanitakis, S., Sollich, V., et al. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199706000-00007 · Cited by 67
Single versus combination intravenous antibiotic therapy for people with cystic fibrosis
Elphick, H., & Jahnke, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002007.pub3 · Cited by 66
Thornton, J., Elliott, R., Tully, M. P., Dodd, M., & Webb, A. K. (2004) · Thorax · doi:10.1136/thx.2003.005876 · Cited by 61
Shifting patterns of inhaled antibiotic use in cystic fibrosis
Moskowitz, S. M., Silva, S. J., Mayer-Hamblett, N., Pasta, D. J., Mink, D. R., Mabie, J. A., Konstan, M. W., & Wagener, J. S. (2008) · Pediatric Pulmonology · doi:10.1002/ppul.20873 · Cited by 61
SELF-ADMINISTERED HOME INTRAVENOUS ANTIBIOTIC THERAPY IN BRONCHIECTASIS AND ADULT CYSTIC FIBROSIS
Winter, R. J. D., Deacock, S. J., George, R. J. D., Shee, C. D., & Geddes, D. M. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91829-4 · Cited by 60
Pharmacodynamic optimization of β-lactams in the patient care setting
Nicolau, D. P. (2008) · Critical Care · doi:10.1186/cc6818 · Cited by 57
Oral Corticosteroid Therapy in Cystic Fibrosis Patients Hospitalized for Pulmonary Exacerbation
Dovey, M. E., Aitken, M. L., Emerson, J., McNamara, S., Waltz, D. A., & Gibson, R. L. (2007) · CHEST Journal · doi:10.1378/chest.07-0843 · Cited by 55
Nazer, D., Abdulhamid, I. B., Thomas, R., & Pendleton, S. M. (2006) · Pediatric Pulmonology · doi:10.1002/ppul.20433 · Cited by 53
Bosso, J. A., Black, P. G., & Jm, M. (1987) · PubMed · Cited by 53
Single Daily Dosing of Aminoglycosides
Preston, S. L., & Briceland, L. L. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04368.x · Cited by 51
Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis
Esmond, G., Butler, M. J., & McCormack, A. M. (2005) · Journal of Clinical Nursing · doi:10.1111/j.1365-2702.2005.01236.x · Cited by 43
Home intravenous antibiotics for cystic fibrosis
la Cruz, O. A.-D., Bosque, M., Marco, T., de Gracia, J., & Serra, C. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001917 · Cited by 41
Yi, M., Tsevat, J., Wilmott, R. W., Kotagal, U. R., & Britto, M. T. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.032 · Cited by 39
Oral anti-pseudomonal antibiotics for cystic fibrosis
Remmington, T., Jahnke, N., & Harkensee, C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005405.pub4 · Cited by 36
Waters, V. J., & Ratjen, F. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006961.pub4 · Cited by 34
Aaron, S. D. (2007) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2007.04.005 · Cited by 29
Jackson, M. A., Kusmiesz, H., Shelton, S., et al. (1986) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198607000-00014 · Cited by 26
Cited by
Elborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
Airway Mucus Function and Dysfunction
Fahy, J. V., & Dickey, B. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0910061 · Cited by 1,722
ECFS best practice guidelines: the 2018 revision
Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.02.006 · Cited by 765
Self-citationThe Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
European cystic fibrosis society standards of care: best practice guidelines
Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.03.010 · Cited by 582
Self-citation
Metadata
- Authors
- Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11-01
- Volume
- 180
- Issue
- 9
- Pages
- 802-808
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2146292644
- Cited by
- 738
- References
- 69
- FWCI
- 27.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.